Mind Body Syndrome Therapy for Chronic Pain

Sponsor
Beth Israel Deaconess Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04689646
Collaborator
(none)
150
1
3
41.4
3.6

Study Details

Study Description

Brief Summary

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates anxiety related to the pain and other quality of life parameters.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mind Body Intervention 1
  • Behavioral: Mind body intervention 2
N/A

Detailed Description

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to usual care (control arm) and an active control arm. The investigators will secondarily investigate whether the intervention alleviates anxiety related to the pain and other quality of life parameters.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Mind-Body Intervention 1, Mind-Body Intervention 2 and Usual CareMind-Body Intervention 1, Mind-Body Intervention 2 and Usual Care
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Double (Participant, Outcomes Assessor) Participants will be partially blinded. Participants in the usual care arm will be blinded to the specifics of the interventions. Participants in Mind-Body Intervention 2 arm will be blinded to the specifics of the interventions. Intervention participants will be blinded to the specifics of the intervention until after they have been randomized into that arm. Data analysis will be conducted by persons who are completely blinded.
Primary Purpose:
Treatment
Official Title:
Mind Body Syndrome Therapy for the Treatment of Chronic Pain
Actual Study Start Date :
May 20, 2021
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mind-Body Intervention 1

Participants will receive a mind body educational based intervention to learn the techniques comprising intervention 1.

Behavioral: Mind Body Intervention 1
Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.

Active Comparator: Mind-Body Intervention 2

Participants will receive a mind body educational based intervention to learn the techniques comprising intervention 2.

Behavioral: Mind body intervention 2
Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.

No Intervention: Usual Care

Participants will continue their usual care for 26 weeks

Outcome Measures

Primary Outcome Measures

  1. Pain Disability [26 weeks]

    Roland Morris Disability Index (Scale 0-24 with 24 being worst)

Secondary Outcome Measures

  1. Average pain [Baseline, 4, 8, 13, and 26 weeks after initiation of the study.]

    Average pain as determined in the Brief Pain Inventory Survey (Scale 0-10 with 10 being worst)

  2. Pain Bothersomeness (Back Specific): Brief Pain Inventory Survey [Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks]

    Back pain bothersomeness as determined from modified Brief Pain Inventory Survey. (Scale 0-10 with 10 being the worst

  3. Pain bothersomeness: Brief Pain Inventory [Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks]

    Whole-body pain bothersomeness as determined from modified Brief Pain Inventory Survey (Scale of 0-10 with 10 being the worst)

  4. Anxiety from pain [Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks]

    Anxiety from pain as determined from the Pain Anxiety Symptom Scale-20 survey (20 questions with scale of 0-5 with 5 being 'always' and 0 being 'never'

  5. Self-reported hospital admissions [Baseline, 26 weeks]

    Self reported. Number of pain-related hospital admissions, including emergency room visits

  6. Complete resolution of pain disability [Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks]

    complete resolution of pain disability as measured by Roland Morris Disability (Scale 0-24 with 24 being worst)

  7. Pain affecting enjoyment of life [Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks]

    Scale 0-10 with 10 being worst from Brief Pain Inventory

  8. Complete resolution of back pain [Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks]

    complete resolution of pain as measured on scale 0-10

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 67 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patient 18 ≥ years old

  • Chronic back pain

  • Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment

  • Willingness to consider mind-body intervention

  • At least score of 2 or more on Roland Disability Questionnaire

  • At least score of 3 or more back pain bothersomeness

Exclusion Criteria:
  • Patients < 18 years of age

  • Patients > 67 years of age

  • Diagnosed organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome (note that pain related to disc disease is not an exclusion unless there are neurological impairments)

  • Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia, and bipolar disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215

Sponsors and Collaborators

  • Beth Israel Deaconess Medical Center

Investigators

  • Principal Investigator: Michael Donnino, MD, Beth Israel Deaconess Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Donnino, Associate Professor of Emergency Medicine, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT04689646
Other Study ID Numbers:
  • 2020P000147
First Posted:
Dec 30, 2020
Last Update Posted:
Dec 8, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 8, 2021